K M Kunisaki

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study
    Ken M Kunisaki
    Pulmonary Section, Minneapolis Veterans Affairs Medical Center, Minnesota 55417, USA
    Am J Respir Crit Care Med 185:286-90. 2012
  2. ncbi Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study
    Ken M Kunisaki
    Division of Pulmonary, Allergy, Critical Care and Sleep, University of Minnesota, USA
    Ther Adv Respir Dis 2:55-64. 2008
  3. ncbi Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
    Ken M Kunisaki
    Pulmonary Section, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN 55417, USA
    Lancet Infect Dis 9:493-504. 2009
  4. ncbi Vitamin D status and longitudinal lung function decline in the Lung Health Study
    K M Kunisaki
    Minneapolis Veterans Affairs Medical Center, Pulmonary, Minneapolis, MN 55417, USA
    Eur Respir J 37:238-43. 2011
  5. ncbi Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease
    Ken M Kunisaki
    Pulmonary Section, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN 55417, USA
    Int J Chron Obstruct Pulmon Dis 6:29-34. 2011
  6. ncbi Contemporary issues in the diagnosis and treatment of obstructive sleep apnea
    Jeffrey B Rubins
    Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USA
    Postgrad Med 120:46-52. 2008
  7. ncbi Managing stable COPD in 2009: incorporating results from recent clinical studies into a goal-directed approach for clinicians
    Jeffrey B Rubins
    Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USA
    Postgrad Med 121:104-12. 2009
  8. ncbi Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence
    Ken M Kunisaki
    University of Minnesota, Minneapolis, Minnesota, USA
    Drugs Aging 24:303-24. 2007
  9. ncbi Role of tiotropium in the treatment of COPD
    Kathryn L Rice
    University of Minnesota, Minneapolis, MN, USA
    Int J Chron Obstruct Pulmon Dis 2:95-105. 2007

Research Grants

  1. Effects of HIV antiretroviral therapy on pulmomary function in a randomized trial
    Ken M Kunisaki; Fiscal Year: 2010

Detail Information

Publications9

  1. ncbi Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study
    Ken M Kunisaki
    Pulmonary Section, Minneapolis Veterans Affairs Medical Center, Minnesota 55417, USA
    Am J Respir Crit Care Med 185:286-90. 2012
    ..We hypothesized that low blood levels of 25(OH)D in patients with chronic obstructive pulmonary disease (COPD) would be associated with an increased risk of acute exacerbations of COPD (AECOPD)...
  2. ncbi Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study
    Ken M Kunisaki
    Division of Pulmonary, Allergy, Critical Care and Sleep, University of Minnesota, USA
    Ther Adv Respir Dis 2:55-64. 2008
    ..We evaluated the ability of exhaled nitric oxide (FENO) and serum inflammatory markers (C-reactive protein [CRP], interleukin-6 [IL-6], and interleukin-8 [IL-8]) to independently predict spirometric responses to ICS in patients with COPD...
  3. ncbi Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
    Ken M Kunisaki
    Pulmonary Section, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN 55417, USA
    Lancet Infect Dis 9:493-504. 2009
    ..Randomised clinical trial data were limited to one study of HIV-infected patients with high vaccine efficacy. Better trial data would inform vaccination recommendations on the basis of efficacy and cost in these at-risk populations...
  4. ncbi Vitamin D status and longitudinal lung function decline in the Lung Health Study
    K M Kunisaki
    Minneapolis Veterans Affairs Medical Center, Pulmonary, Minneapolis, MN 55417, USA
    Eur Respir J 37:238-43. 2011
    ..Although vitamin D insufficiency and deficiency are common among continuous smokers with established mild-to-moderate chronic obstructive pulmonary disease, baseline 25(OH)D levels are not predictive of subsequent lung function decline...
  5. ncbi Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease
    Ken M Kunisaki
    Pulmonary Section, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN 55417, USA
    Int J Chron Obstruct Pulmon Dis 6:29-34. 2011
    ..The objective of this study was to determine whether serum levels of 25(OH)D were related to ICS responses in patients with COPD...
  6. ncbi Contemporary issues in the diagnosis and treatment of obstructive sleep apnea
    Jeffrey B Rubins
    Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USA
    Postgrad Med 120:46-52. 2008
    ..However, these devices must be used as part of a comprehensive sleep evaluation program that includes access to board-certified sleep specialists, PSG facilities, and therapists experienced in fitting and troubleshooting CPAP devices...
  7. ncbi Managing stable COPD in 2009: incorporating results from recent clinical studies into a goal-directed approach for clinicians
    Jeffrey B Rubins
    Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USA
    Postgrad Med 121:104-12. 2009
    ..We reviewed recent clinical trials to develop concepts of care for the non-specialist clinician managing patients with stable COPD...
  8. ncbi Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence
    Ken M Kunisaki
    University of Minnesota, Minneapolis, Minnesota, USA
    Drugs Aging 24:303-24. 2007
    ..Mucolytic agents, pulmonary rehabilitation, and case management programmes may also reduce exacerbation risk, but the current evidence supporting these interventions is weaker...
  9. ncbi Role of tiotropium in the treatment of COPD
    Kathryn L Rice
    University of Minnesota, Minneapolis, MN, USA
    Int J Chron Obstruct Pulmon Dis 2:95-105. 2007
    ..Medico economic analyses suggest that treatment with tiotropium may also be cost-effective, primarily by reducing costs associated with hospitalizations...

Research Grants2

  1. Effects of HIV antiretroviral therapy on pulmomary function in a randomized trial
    Ken M Kunisaki; Fiscal Year: 2010
    ..This study will determine if early treatment of HIV might reduce this risk. (End of Abstract) ..